Noninvasive identification of HER2-zero, -low, or -overexpressing breast cancers: Multiparametric MRI-based quantitative characterization in predicting HER2-low status of breast cancer

• DOI: 10.1016/j.ejrad.2024.111573
• Publication Date: 2024-06-15T22:33:23Z
• Authors: Ting Zhan; Jiankun Dai; Yan Li
• Keywords: Multiparametric MRI; Breast MRI

To evaluate the effectiveness of both synthetic magnetic resonance imaging (SyMRI) and conventional diffusion-weighted (DWI) for identifying human epidermal growth factor receptor 2 (HER2) status in breast cancer (BC) patients.